Determination of aglycones of ginsenosides in ginseng preparations sold in Sweden and in urine samples from Swedish athletes consuming ginseng

被引:38
作者
Cui, JF
Garle, M
Bjorkhem, I
Eneroth, P
机构
[1] HUDDINGE UNIV HOSP, KAROLINSKA INST, DIV CLIN CHEM, DEPT MED LAB SCI & TECHNOL, STOCKHOLM, SWEDEN
[2] HUDDINGE UNIV HOSP, KAROLINSKA INST, CLIN RES CTR, STOCKHOLM, SWEDEN
关键词
gas chromatography; identification; liquid formulations; mass spectrometry; prosapogenins; quantification; sapogenins;
D O I
10.3109/00365519609088602
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Recently developed gas chromatographic and gas chromatographic-mass spectrometric methods were used to characterize 17 different commercial ginseng preparations sold in Sweden. The contents of total ginsenosides per capsule or per tablet varied from 2.1 to 13.3 mg. Unlike the other preparations, a red ginseng and three liquid ginseng preparations (after releasing the sugar moieties from ginsenosides) were shown also to contain significant amounts of 20-epimers of 20(S)-protopanaxadiol and 20(S)-protopanaxatriol as well as their corresponding 24,25-hydrated compounds. In addition to the genuine and artificial sapogenins mentioned above, two epimeric pairs of prosapogenines (ginsenoside Rg(3) and 20 (S)-Rg(3), ginsenoside Rh-1 and 20(R)-Rh-1) were also found in the liquid formulations. These results suggest that hydrolysis, epimerization and hydration in the side-chain of the aglycone moiety of ginsenosides may occur in the liquid formulations under weak acidic conditions (pH 3.0-3.5 with 9-10% of alcohol at room temperature). The new method was also used to determine the aglycones of ginsenosides in urine samples from Swedish athletes stating that they had consumed ginseng preparations within 10 days before urine collection. Out of the 65 samples analysed, 60 were found to contain 20(S)-protopanaxatriol. The concentrations of 20(S)-protopanaxatriol ginsenosides varied from 2 to 35 ng ml(-1) urine. This is the first demonstration of uptake of ginsenosides in humans after oral administration of ginseng preparations.
引用
收藏
页码:151 / 160
页数:10
相关论文
共 18 条
  • [1] BAEK NI, P 6 INT GINS S SEOUL, P132
  • [2] CHEN Y, 1987, CHEM PHARM BULL, V35, P1653
  • [3] NOVEL MECHANISM FOR OXIDATIVE CLEAVAGE OF GLYCOSIDIC BONDS - EVIDENCE FOR AN OXYGEN-DEPENDENT REACTION
    CUI, JF
    BYSTROM, S
    ENEROTH, P
    BJORKHEM, I
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1994, 59 (26) : 8251 - 8255
  • [4] IDENTIFICATION AND QUANTIFICATION OF GINSENOSIDES IN VARIOUS COMMERCIAL GINSENG PREPARATIONS
    CUI, JF
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 3 (02) : 77 - 85
  • [5] ANALYSIS OF GINSENOSIDES BY CHROMATOGRAPHY AND MASS-SPECTROMETRY - RELEASE OF 20 S-PROTOPANAXADIOL AND 20 S-PROTOPANAXATRIOL FOR QUANTITATION
    CUI, JF
    GARLE, M
    LUND, E
    BJORKHEM, I
    ENEROTH, P
    [J]. ANALYTICAL BIOCHEMISTRY, 1993, 210 (02) : 411 - 417
  • [6] DENG HL, 1991, CHINESE MED J-PEKING, V104, P395
  • [7] DEGRADATION OF GINSENG SAPONINS UNDER MILD ACIDIC CONDITIONS
    HAN, BH
    PARK, MH
    HAN, YN
    WOO, LK
    SANKAWA, U
    YAHARA, S
    TANAKA, O
    [J]. PLANTA MEDICA, 1982, 44 (03) : 146 - 149
  • [8] LIVER-PROTECTIVE DRUGS .18. ANTIHEPATOTOXIC ACTIONS OF GINSENOSIDES FROM PANAX-GINSENG ROOTS
    HIKINO, H
    KISO, Y
    KINOUCHI, J
    SANADA, S
    SHOJI, J
    [J]. PLANTA MEDICA, 1985, 51 (01) : 62 - 64
  • [9] KASAI R, 1983, CHEM PHARM BULL, V31, P2120
  • [10] KIM HY, 1992, BIOCHEM BIOPH RES CO, V189, P670